Eisai: Antiepileptic Drug Fycompa Injection Formulation Approved In Japan

Addressing Medical Needs for Treatment Through a Non-Oral Administration Route TOKYO, Jan 18, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has obtained marketing authorization approval from the Japanese Ministry of Health, Labour and ...

Related Keywords

United States ,Tokyo ,Japan ,China ,Japanese , ,National Institute Of Neurological Disorders ,Catalyst Pharmaceuticals Inc ,Hope Through Research ,Eisai Tsukuba Research Laboratories ,Oral Administration Route ,Eisai Co Ltd ,Japanese Ministry Of Health ,Medical Needs ,Treatment Through ,Non Oral Administration ,Japanese Ministry ,Tsukuba Research ,Catalyst Pharmaceuticals ,Hope Through ,Neurological Disorders ,Jcn Newswire ,World ,Healthcare Industry ,Nformative ,Medical ,Science ,Orld Asia ,Scoop ,